Advanced Research on Psychiatric Disorders

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 738

Special Issue Editor


E-Mail Website
Guest Editor
Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, FL, USA
Interests: computational genetics; neuropsychiatric disorder; big data analysis; deep learning; statistical modelling; bioinformatics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Psychiatric disorders represent a major challenge to global public health, with complex etiologies that involve intricate interactions between genetic, environmental, and neurological factors. This Special Issue, "Advanced Research on Psychiatric Disorders", aims to highlight cutting-edge developments in understanding, diagnosing, and treating psychiatric illnesses. We welcome contributions that explore the biological underpinnings of psychiatric disorders, particularly studies examining their correlations with neurodegenerative and neurological diseases.

In addition, this Special Issue seeks to showcase innovative applications of artificial intelligence (AI) and machine learning in psychiatric research, including predictive modeling, biomarker discovery, and personalized treatment strategies. Studies employing animal experiments to elucidate disease mechanisms, therapeutic responses, or novel intervention strategies are highly encouraged. Genetic studies that uncover risk factors, molecular mechanisms, and potential therapeutic targets are also of great interest. We especially welcome translational medicine research that bridges experimental findings to clinical applications, aiming to accelerate the development of effective treatments. Multimodal approaches integrating neuroimaging, genomics, clinical data, and computational methods will be of particular interest.

By gathering diverse methodologies and interdisciplinary perspectives, this Special Issue aims to advance our understanding of psychiatric disorders and open new avenues for early diagnosis, intervention, and personalized care. We invite researchers from psychiatry, neuroscience, bioinformatics, genetics, translational medicine, and personalized medicine to contribute original research articles, reviews, and perspectives to this timely and impactful collection.

Dr. Wen Zhang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psychiatric disorders
  • artificial intelligence
  • predictive modeling
  • personalized treatment strategies
  • animal experiments
  • risk factors
  • multimodal approaches

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

9 pages, 1171 KiB  
Perspective
Is Cerebrolysin Useful in Psychiatry Disorders?
by Szymon Florek, Patryk Główczyński, Karina Badura-Brzoza and Robert Pudlo
Biomedicines 2025, 13(7), 1661; https://doi.org/10.3390/biomedicines13071661 - 8 Jul 2025
Viewed by 294
Abstract
Background/Objectives: Cerebrolysin is a well-known mixture of peptides that has been used for many years, primarily in patients with neurological disorders. Thanks to its unique properties, this substance supports endogenous repair mechanisms and protects the brain from damaging factors. Cerebrolysin is most [...] Read more.
Background/Objectives: Cerebrolysin is a well-known mixture of peptides that has been used for many years, primarily in patients with neurological disorders. Thanks to its unique properties, this substance supports endogenous repair mechanisms and protects the brain from damaging factors. Cerebrolysin is most widely used in Eastern European countries. However, data on the potential use of cerebrolysin in mental disorders are difficult to find in the literature. This review focuses on the potential use of cerebrolysin in psychiatry, and two independent researchers searched three full-text medical article databases to compile it. Methods: To conduct this scoping review, two independent researchers searched three full-text article databases, Embase, Scopus, and Web of Science, by entering the following phrases: “cerebrolysin psychiatry”, “cerebrolysin depression”, “cerebrolysin mood”, “cerebrolysin bipolar”, “cerebrolysin schizophrenia”, and “cerebrolysin addiction”. Results: The results show that this specific substance could have a relatively small application in psychiatry. Conclusions: The limited amount of available research on the use of cerebrolysin suggests that it may have some significance in supporting the treatment of depression and autism spectrum disorders and alleviating adverse effects during treatment with neuroleptics. Full article
(This article belongs to the Special Issue Advanced Research on Psychiatric Disorders)
Show Figures

Figure 1

Back to TopTop